{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:03:30Z","timestamp":1791000210277,"version":"4.1.0"},"reference-count":70,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T00:00:00Z","timestamp":1640908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011724","name":"Muscular Dystrophy UK","doi-asserted-by":"publisher","award":["19GROE-PG24-0349-2"],"award-info":[{"award-number":["19GROE-PG24-0349-2"]}],"id":[{"id":"10.13039\/100011724","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In the UK, large-scale electronic primary care datasets can provide up-to-date, accurate epidemiological information on rarer diseases, where specialist diagnoses from hospital discharges and clinic letters are generally well recorded and electronically searchable. Current estimates of the number of people living with neuromuscular disease (NMD) have largely been based on secondary care data sources and lacked direct denominators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To estimate trends in the recording of neuromuscular disease in UK primary care between 2000\u20132019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The Clinical Practice Research Datalink (CPRD) database was searched electronically to estimate incidence and prevalence rates (per 100,000) for a range of NMDs in each year. To compare trends over time, rates were age standardised to the most recent CPRD population (2019).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Approximately 13 million patients were actively registered in each year. By 2019, 28,230 active patients had ever received a NMD diagnosis (223.6), which was higher among males (239.0) than females (208.3). The most common classifications were Guillain-Barre syndrome (40.1), myasthenia gravis (33.7), muscular dystrophy (29.5), Charcot-Marie-Tooth (29.5) and inflammatory myopathies (25.0). Since 2000, overall prevalence grew by 63%, with the largest increases seen at older ages (\u226565-years). However, overall incidence remained constant, though myasthenia gravis incidence has risen steadily since 2008, while new cases of muscular dystrophy fell over the same period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec005\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Lifetime recording of many NMDs on primary care records exceed current estimates of people living with these conditions; these are important data for health service and care planning. Temporal trends suggest this number is steadily increasing, and while this may partially be due to better recording, it cannot be simply explained by new cases, as incidence remained constant. The increase in prevalence among older ages suggests increases in life expectancy among those living with NMDs may have occurred.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0261983","type":"journal-article","created":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T13:27:41Z","timestamp":1640957261000},"page":"e0261983","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":63,"title":["Prevalence and incidence of neuromuscular conditions in the UK between 2000 and 2019: A retrospective study using primary care data"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1099-8460","authenticated-orcid":true,"given":"Iain M.","family":"Carey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Banchoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niranjanan","family":"Nirmalananthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tess","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"DeWilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umar A. R.","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek G.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,12,31]]},"reference":[{"issue":"4","key":"pone.0261983.ref001","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.ncl.2016.06.017","article-title":"The Epidemiology of Neuromuscular Diseases","volume":"34","author":"JM Bhatt","year":"2016","journal-title":"Neurol Clin"},{"issue":"3","key":"pone.0261983.ref002","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00415-014-7585-3","article-title":"Adult care for Duchenne muscular dystrophy in the UK","volume":"262","author":"S Rodger","year":"2015","journal-title":"J Neurol"},{"issue":"24","key":"pone.0261983.ref003","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Medical Progress Guillain-Barre Syndrome","volume":"366","author":"N Yuki","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"pone.0261983.ref004","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","article-title":"Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database","volume":"28","author":"S Nguengang Wakap","year":"2020","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"pone.0261983.ref005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3233\/JND-140045","article-title":"The Epidemiology of Neuromuscular Disorders: A Comprehensive Overview of the Literature","volume":"2","author":"JCW Deenen","year":"2015","journal-title":"Journal of neuromuscular diseases"},{"key":"pone.0261983.ref006","unstructured":"All Party Parliamentary Group for Muscular Dystrophy. Impact of NHS reforms on access to neuromuscular services. 2015: https:\/\/www.musculardystrophyuk.org\/wp-content\/uploads\/2015\/03\/APPG-for-Muscular-Dystrophy-report-impact-of-NHS-reforms-on-access-to-neuromuscular-services.pdf."},{"key":"pone.0261983.ref007","unstructured":"Public Health England. Deaths Associated with Neurological Conditions in England. 2018: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/683998\/Deaths_associated_with_neurological_conditions_data_briefing.pdf. Accessed 12-07-2021."},{"key":"pone.0261983.ref008","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1093\/brain\/awp236","article-title":"Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population","volume":"132","author":"FLM Norwood","year":"2009","journal-title":"Brain"},{"issue":"3","key":"pone.0261983.ref009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210574","article-title":"Trends in incidence, prevalence, and mortality of neuromuscular disease in Ontario, Canada: A population-based retrospective cohort study (2003\u20132014)","volume":"14","author":"L Rose","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"pone.0261983.ref010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2125.2009.03537.x","article-title":"Validation and validity of diagnoses in the General Practice Research Database: a systematic review","volume":"69","author":"E Herrett","year":"2010","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"pone.0261983.ref011","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data Resource Profile: Clinical Practice Research Datalink (CPRD)","volume":"44","author":"E Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"2","key":"pone.0261983.ref012","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020738","article-title":"Spatial distribution of clinical computer systems in primary care in England in 2016 and implications for primary care electronic medical record databases: a cross-sectional population study","volume":"8","author":"E Kontopantelis","year":"2018","journal-title":"Bmj Open"},{"issue":"6","key":"pone.0261983.ref013","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/ije\/dyz034","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum","volume":"48","author":"A Wolf","year":"2019","journal-title":"Int J Epidemiol"},{"issue":"6732","key":"pone.0261983.ref014","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/bmj.300.6732.1092","article-title":"The Read clinical classification","volume":"300","author":"J. Chisholm","year":"1990","journal-title":"BMJ"},{"key":"pone.0261983.ref015","unstructured":"Office for National Statistics. Population estimates for the UK, England and Wales, Scotland and Northern Ireland: mid-2019. 2020: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationestimates\/bulletins\/annualmidyearpopulationestimates\/mid2019estimates. Accessed 07-09-2021."},{"key":"pone.0261983.ref016","unstructured":"National Institute of Neurological Disorders and Stroke. Guillain-Barr\u00e9 Syndrome Fact Sheet. 2018: https:\/\/www.ninds.nih.gov\/Disorders\/Patient-Caregiver-Education\/Fact-Sheets\/Guillain-Barr%C3%A9-Syndrome-Fact-Sheet. Accessed 27-08-2021."},{"key":"pone.0261983.ref017","unstructured":"Muscular Dystrophy Campaign. Muscle disease: the impact. Incidence and Prevalence of Neuromuscular Conditions in the UK. London2010: https:\/\/www.musculardystrophyuk.org\/get-involved\/campaign\/our-reports. Accessed 16-01-2019."},{"issue":"1","key":"pone.0261983.ref018","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/jnnp-2013-305450","article-title":"Incidence and prevalence of multiple sclerosis in the UK 1990\u20132010: a descriptive study in the General Practice Research Database","volume":"85","author":"IS Mackenzie","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"pone.0261983.ref019","unstructured":"Parkinson\u2019s UK. The prevalence and incidence of Parkinson\u2019s in the UK. 2017: https:\/\/www.parkinsons.org.uk\/sites\/default\/files\/2018-01\/Prevalence%20%20Incidence%20Report%20Latest_Public_2.pdf. Accessed 27-08-2021."},{"issue":"3","key":"pone.0261983.ref020","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1212\/WNL.0000000000003504","article-title":"A population-based epidemiologic study of adult neuromuscular disease in the Republic of Ireland","volume":"88","author":"S Lefter","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"pone.0261983.ref021","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1948","article-title":"The prevalence of hereditary neuromuscular disorders in Northern Norway","volume":"11","author":"KI Muller","year":"2021","journal-title":"Brain Behav"},{"key":"pone.0261983.ref022","article-title":"Prevalence and healthcare utilization of rare neurological diseases in Hong Kong: 2014\u20132018","volume":"8","author":"ATG Chiu","year":"2021","journal-title":"Eur J Neurol"},{"issue":"12","key":"pone.0261983.ref023","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1474-4422(18)30404-6","article-title":"Global, regional, and national burden of motor neuron diseases 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"G Logroscino","year":"2018","journal-title":"Lancet Neurol"},{"issue":"2","key":"pone.0261983.ref024","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000351153","article-title":"Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature","volume":"41","author":"A Chio","year":"2013","journal-title":"Neuroepidemiology"},{"issue":"1","key":"pone.0261983.ref025","first-page":"57","article-title":"Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis","volume":"46","author":"B Marin","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"4","key":"pone.0261983.ref026","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s00415-019-09652-y","article-title":"Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"267","author":"L Xu","year":"2020","journal-title":"J Neurol"},{"issue":"8","key":"pone.0261983.ref027","doi-asserted-by":"crossref","first-page":"e1227","DOI":"10.1212\/WNL.0000000000011467","article-title":"Incidence, Prevalence, and Geographical Clustering of Motor Neuron Disease in the Netherlands","volume":"96","author":"AD de Jongh","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"pone.0261983.ref028","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1038\/s41598-021-85395-z","article-title":"Estimation of the prevalence and incidence of motor neuron diseases in two Spanish regions","volume":"11","author":"MA Barcel\u00f3","year":"2021","journal-title":"Catalonia and Valencia. Scientific Reports"},{"issue":"Suppl 3","key":"pone.0261983.ref029","doi-asserted-by":"crossref","first-page":"465.3","DOI":"10.1136\/annrheumdis-2012-eular.2904","article-title":"FRI0447 Epidemiology of idiopathic inflammatory myopathies in england\u2014a database analysis","volume":"71","author":"TN Tran","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"pone.0261983.ref030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/rheumatology\/keu289","article-title":"Incidence and prevalence of inflammatory myopathies: a systematic review","volume":"54","author":"A Meyer","year":"2015","journal-title":"Rheumatology"},{"issue":"5","key":"pone.0261983.ref031","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/rheumatology\/kew503","article-title":"Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study","volume":"56","author":"J Svensson","year":"2017","journal-title":"Rheumatology"},{"issue":"3","key":"pone.0261983.ref032","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/14397595.2013.844308","article-title":"Prevalence and incidence of polymyositis and dermatomyositis in Japan","volume":"24","author":"A Ohta","year":"2014","journal-title":"Mod Rheumatol"},{"issue":"8","key":"pone.0261983.ref033","article-title":"Incidence and Prevalence of Idiopathic Inflammatory Myopathies in Korea: a Nationwide Population-based Study","volume":"34","author":"SK Cho","year":"2019","journal-title":"J Korean Med Sci"},{"issue":"6","key":"pone.0261983.ref034","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","article-title":"A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy","volume":"24","author":"JK Mah","year":"2014","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"pone.0261983.ref035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/cjn.2015.311","article-title":"A Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies","volume":"43","author":"JK Mah","year":"2016","journal-title":"Can J Neurol Sci"},{"issue":"3\u20134","key":"pone.0261983.ref036","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000369343","article-title":"Prevalence of Muscular Dystrophies: A Systematic Literature Review","volume":"43","author":"A Theadom","year":"2014","journal-title":"Neuroepidemiology"},{"issue":"1","key":"pone.0261983.ref037","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-020-01430-8","article-title":"Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis","volume":"15","author":"S Crisafulli","year":"2020","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"pone.0261983.ref038","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0960-8966(94)00017-4","article-title":"The prevalence of inherited neuromuscular disease in Northern Ireland","volume":"6","author":"MI Hughes","year":"1996","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"pone.0261983.ref039","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000443706","article-title":"Epidemiologic Study of Charcot-Marie-Tooth Disease: A Systematic Review","volume":"46","author":"L Barreto","year":"2016","journal-title":"Neuroepidemiology"},{"issue":"5","key":"pone.0261983.ref040","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/jnnp-2011-300285","article-title":"Charcot-Marie-Tooth disease in Northern England","volume":"83","author":"C Foley","year":"2012","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"issue":"5","key":"pone.0261983.ref041","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/WCO.0000000000000735","article-title":"Charcot-Marie-Tooth disease and related disorders: an evolving landscape","volume":"32","author":"M Laura","year":"2019","journal-title":"Curr Opin Neurol"},{"issue":"17","key":"pone.0261983.ref042","doi-asserted-by":"crossref","first-page":"E2027","DOI":"10.1212\/WNL.0000000000007376","article-title":"Cost of illness in Charcot-Marie-Tooth neuropathy Results from Germany","volume":"92","author":"E Schorling","year":"2019","journal-title":"Neurology"},{"issue":"2","key":"pone.0261983.ref043","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000184748","article-title":"The Epidemiology of Guillain-Barre Syndrome Worldwide A Systematic Literature Review","volume":"32","author":"A McGrogan","year":"2009","journal-title":"Neuroepidemiology"},{"issue":"2","key":"pone.0261983.ref044","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population Incidence of Guillain-Barre Syndrome: A Systematic Review and Meta-Analysis","volume":"36","author":"JJ Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"issue":"8","key":"pone.0261983.ref045","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/cid\/ciu005","article-title":"Guillain-Barre Syndrome, Influenza, and Influenza Vaccination: The Epidemiologic Evidence","volume":"58","author":"C Vellozzi","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"2","key":"pone.0261983.ref046","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00415-018-9151-x","article-title":"Guillain-Barre syndrome in Denmark: a population-based study on epidemiology, diagnosis and clinical severity","volume":"266","author":"H Al-Hakem","year":"2019","journal-title":"J Neurol"},{"issue":"13","key":"pone.0261983.ref047","doi-asserted-by":"crossref","first-page":"E1220","DOI":"10.1212\/WNL.0000000000006246","article-title":"Surgery and risk of Guillain-Barre syndrome A French nationwide epidemiologic study","volume":"91","author":"J Rudant","year":"2018","journal-title":"Neurology"},{"issue":"4","key":"pone.0261983.ref048","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/jns.12239","article-title":"Epidemiology of Guillain-Barre syndrome in Finland 2004\u20132014","volume":"22","author":"JOT Sipila","year":"2017","journal-title":"J Peripher Nerv Syst"},{"issue":"16","key":"pone.0261983.ref049","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.vaccine.2013.02.009","article-title":"Algorithms for identification of Guillain-Barre Syndrome among adolescents in claims databases","volume":"31","author":"D Funch","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"pone.0261983.ref050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/jns.12202","article-title":"Guillain-Barre syndrome in France: a nationwide epidemiological analysis based on hospital discharge data (2008\u20132013)","volume":"22","author":"A Delannoy","year":"2017","journal-title":"J Peripher Nerv Syst"},{"key":"pone.0261983.ref051","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2147\/CLEP.S199839","article-title":"Guillain-Barre syndrome in Denmark: validation of diagnostic codes and a population-based nationwide study of the incidence in a 30-year period","volume":"11","author":"LS Levison","year":"2019","journal-title":"Clin Epidemiol"},{"issue":"1","key":"pone.0261983.ref052","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12974-021-02319-4","article-title":"Global, regional, and national burden of Guillain-Barre syndrome and its underlying causes from 1990 to 2019","volume":"18","author":"NL Bragazzi","year":"2021","journal-title":"J Neuroinflammation"},{"issue":"9","key":"pone.0261983.ref053","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-037909","article-title":"Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America","volume":"10","author":"JD Green","year":"2020","journal-title":"Bmj Open"},{"key":"pone.0261983.ref054","first-page":"103","article-title":"Characterizing the Epidemiology of Myasthenia Gravis and Neuromyelitis Optica Using the Clinical Practice Research Datalink","volume":"25","author":"JA Cole","year":"2016","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"1","key":"pone.0261983.ref055","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in Myasthenia Gravis","volume":"10","author":"AS Carr","year":"2010","journal-title":"BMC Neurol"},{"issue":"3","key":"pone.0261983.ref056","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000279334","article-title":"The Incidence of Myasthenia Gravis: A Systematic Literature Review","volume":"34","author":"A McGrogan","year":"2010","journal-title":"Neuroepidemiology"},{"issue":"11","key":"pone.0261983.ref057","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1819","article-title":"Epidemiology of Myasthenia Gravis in Sweden 2006\u20132016","volume":"10","author":"E Westerberg","year":"2020","journal-title":"Brain Behav"},{"issue":"1","key":"pone.0261983.ref058","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000512973","article-title":"Myasthenia Gravis in Poland: National Healthcare Database Epidemiological Study","volume":"55","author":"E Sobieszczuk","year":"2021","journal-title":"Neuroepidemiology"},{"issue":"1","key":"pone.0261983.ref059","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nmd.2015.10.009","article-title":"Epidemiology of myasthenia gravis in Ontario","volume":"26","author":"A Breiner","year":"2016","journal-title":"Canada. Neuromuscul Disord"},{"key":"pone.0261983.ref060","article-title":"Hospital admission and prevalence trends of adult myasthenia gravis in Finland in 2004\u20132014: A retrospective national registry study","volume":"407","author":"JOT Sipila","year":"2019","journal-title":"J Neurol Sci"},{"issue":"21\u201322","key":"pone.0261983.ref061","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00508-012-0258-2","article-title":"Epidemiology of myasthenia gravis in Austria: rising prevalence in an ageing society","volume":"124","author":"H Cetin","year":"2012","journal-title":"Wien Klin Wochen"},{"issue":"4","key":"pone.0261983.ref062","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000328863","article-title":"Change in Myasthenia Gravis Epidemiology in Trento, Italy, after Twenty Years","volume":"36","author":"F Pallaver","year":"2011","journal-title":"Neuroepidemiology"},{"issue":"5","key":"pone.0261983.ref063","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/mus.23964","article-title":"Late-onset myasthenia gravis: a review when incidence in older adults keeps increasing","volume":"48","author":"NM Alkhawajah","year":"2013","journal-title":"Muscle Nerve"},{"issue":"2","key":"pone.0261983.ref064","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/01.ede.0000153643.88019.92","article-title":"Estimating rare disease prevalence from administrative hospitalization databases","volume":"16","author":"MM Ward","year":"2005","journal-title":"Epidemiology"},{"key":"pone.0261983.ref065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-90-481-9485-8_1","article-title":"Rare Diseases\u2014Avoiding Misperceptions and Establishing Realities: The Need for Reliable Epidemiological Data","author":"SC Groft","year":"2010","journal-title":"Rare Diseases Epidemiology"},{"issue":"3","key":"pone.0261983.ref066","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1055\/s-0038-1668090","article-title":"SNOMED CT Concept Hierarchies for Sharing Definitions of Clinical Conditions Using Electronic Health Record Data","volume":"9","author":"DL Willett","year":"2018","journal-title":"Appl Clin Inform"},{"issue":"10","key":"pone.0261983.ref067","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0960-8966(02)00140-2","article-title":"Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation","volume":"12","author":"M Eagle","year":"2002","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"pone.0261983.ref068","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.joca.2020.03.004","article-title":"Trends in incidence and prevalence of osteoarthritis in the United Kingdom: findings from the Clinical Practice Research Datalink (CPRD)","volume":"28","author":"S Swain","year":"2020","journal-title":"Osteoarthritis Cartilage"},{"issue":"3","key":"pone.0261983.ref069","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/bjd.15021","article-title":"Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study","volume":"176","author":"DA Springate","year":"2017","journal-title":"Br J Dermatol"},{"issue":"11","key":"pone.0261983.ref070","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1111\/dom.12964","article-title":"Examining trends in type 2 diabetes incidence, prevalence and mortality in the UK between 2004 and 2014","volume":"19","author":"SS Zghebi","year":"2017","journal-title":"Diabetes, Obesity and Metabolism"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0261983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T13:28:25Z","timestamp":1640957305000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0261983"}},"subtitle":[],"editor":[{"given":"Julie","family":"Dumonceaux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,12,31]]},"references-count":70,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0261983","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,31]]}}}